A versatile design platform for glycoengineering therapeutic antibodies

Seth D. Ludwiga Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD, USAView further author information

Zachary J. Bernsteinb Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USAView further author information

Christian Agatemorb Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA;c Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, USAView further author information

Kris Dammen-Browerb Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USAView further author information

Jeffrey Ruffolod Program in Molecular Biophysics, the Johns Hopkins University, Baltimore, MD, USAView further author information

Jonah M. Rosasa Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD, USAView further author information

Jeremy D. Poste Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD, USAView further author information

Robert N. Colee Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD, USAView further author information

Kevin J. Yaremaa Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD, USA;b Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA;c Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA;f Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA;g Bloomberg–Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USAView further author information

Jamie B. Spanglera Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD, USA;b Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA;c Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA;f Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA;g Bloomberg–Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA;h Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USACorrespondence[email protected]

https://orcid.org/0000-0001-8187-3732 View further author information

show all

A versatile design platform for glycoengineering therapeutic antibodies

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A versatile design platform for glycoengineering therapeutic antibodies

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date